Definitive Contract HHSN261201000062C
Award Date 9/27/10
Potential Completion Date 3/31/15
Potential Value $7.4M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Wilmington, DE 19801, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
9
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $37,262,683.59 definitive cost-no-fee contract awarded by the National Cancer Institute (NCI) to The International Genomics Consortium. The contract is for providing biospecimen processing services to support the Cancer Genome Atlas (TCGA) program, which is part of the National Institutes of Health's efforts to comprehensively characterize various cancer types. The contract has an ultimate completion date of December 30, 2012 and was awarded on September 24, 2010 as part of the...
- <p>This is a definitive contract awarded by the National Cancer Institute, a civilian agency, to The International Genomics Consortium. The contract, with a ceiling value of $21,332,413.15, supports the Cancer Genome Atlas (TCGA) program through the establishment of Tissue Source Site (TSS) networks. The contract does not have a set-aside designation and was awarded on September 27, 2010, with a period of performance through September 30, 2014. The contract is a cost-no-fee contract type.</p>
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The total ceiling value of the contract is $42,000.00. This contract is part of the NCI's Cancer Genome Atlas Program Tissue Purchase master IDIQ contract. The contract...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian federal agency, to Ilsbio LLC, a for-profit limited liability company. The contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. This award is part of the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract and is funded under the American Recovery and Reinvestment Act (ARRA). The contract has a...
- This is a $7,516,300.82 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), to Battelle Memorial Institute, a nonprofit research and development organization. The contract is for a Quality Management System to support the Cancer Genome Atlas (TCGA) project, which was funded under the American Recovery and Reinvestment Act (ARRA). The contract has a period of performance through...
- This is a $41,357,839 definitive cost-no-fee contract awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to the Research Institute at Nationwide Children's Hospital to provide biospecimen processing services for The Cancer Genome Atlas (TCGA) project. This contract supports the American Recovery and Reinvestment Act (ARRA) and has a period of performance through March 30, 2013. There is no set-aside designation for this award. The Research...
- This is a $17,914,968.82 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to General Dynamics Information Technology, Inc. (GDIT), a major IT services provider. The contract supports the Cancer Genome Atlas (TCGA) program by providing tissue samples and data from various types of cancer. It was funded through the American Recovery and Reinvestment Act (ARRA) and has an ultimate...
- <p>The National Cancer Institute awarded a definitive contract to Asterand, Inc. for Tissue Source Site (TSS) networks in support of the Cancer Genome Atlas (TCGA) program on September 24, 2010, with a ceiling value of $23.0 million.</p> <p>The contract is funded under the American Recovery and Reinvestment Act and structured as cost-plus-fixed-fee. Place of performance is Detroit, MI. The ultimate completion date is September 30, 2019.</p>
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), which is part of the Department of Health and Human Services (HHS), to Yale University. The contract is to support the Cancer Genome Atlas (TCGA) program by providing tissue samples and data from various types of cancer, as part of the American Recovery and Reinvestment Act (ARRA). The contract has a ceiling value of $76,875 and a period of performance ending on March 31, 2015. This contract was...
- This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Indivumed, Inc. for the Cancer Genome Atlas (TCGA) program. The $1,337,077.50 contract is to provide tissue samples and data from various types of cancer for the TCGA program, which aims to characterize the genomic changes involved in cancer. The award is not associated with a set-aside program. This delivery order is part of...